Your browser doesn't support javascript.
loading
Remarkable response to gemcitabine rechallenge in advanced urothelial carcinoma: a case report.
Merler, Sara; Pafumi, Sarah; Zampiva, Ilaria; Zacchi, Francesca; Manduca, Stefano; Fantinel, Emanuela; Zivi, Andrea; Milella, Michele.
Afiliación
  • Merler S; Section of Oncology, Department of Medicine, University of Verona.
  • Pafumi S; Section of Oncology, Department of Medicine, University of Verona.
  • Zampiva I; Section of Oncology, Department of Medicine, University of Verona.
  • Zacchi F; Section of Oncology, Department of Medicine, University of Verona.
  • Manduca S; Section of Oncology, Department of Medicine, University of Verona.
  • Fantinel E; Section of Oncology, Department of Medicine, Verona University Hospital Trust (AUOI), Verona, Italy.
  • Zivi A; Section of Oncology, Department of Medicine, Verona University Hospital Trust (AUOI), Verona, Italy.
  • Milella M; Department of Cancer & Surgery, Faculty of Medicine, Imperial College London, London, UK.
Anticancer Drugs ; 33(10): 1171-1174, 2022 11 01.
Article en En | MEDLINE | ID: mdl-36206104
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales Tipo de estudio: Prognostic_studies Límite: Humans / Male Idioma: En Revista: Anticancer Drugs Asunto de la revista: ANTINEOPLASICOS Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales Tipo de estudio: Prognostic_studies Límite: Humans / Male Idioma: En Revista: Anticancer Drugs Asunto de la revista: ANTINEOPLASICOS Año: 2022 Tipo del documento: Article